These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2652803)

  • 1. Advanced liver failure predisposes to cyclosporine-induced central nervous system symptoms after liver transplantation.
    de Groen PC; Wiesner RH; Krom RA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2456. PubMed ID: 2652803
    [No Abstract]   [Full Text] [Related]  

  • 2. Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol.
    de Groen PC; Aksamit AJ; Rakela J; Forbes GS; Krom RA
    N Engl J Med; 1987 Oct; 317(14):861-6. PubMed ID: 3306386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fulminant liver failure before and after introduction of liver transplantation at Rikshospitalet].
    Larsen FS; Ranek L; Hjortrup A; Kirkegaard P; Clemmesen JO; Hansen BA
    Ugeskr Laeger; 1995 Feb; 157(7):885-8. PubMed ID: 7701649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Epstein-Barr virus reactivation after renal transplantation: immunosuppression with cyclosporine versus azathioprine.
    Hillebrand G; Castro LA; Schleibner S; Land W; Gurland HJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2179-80. PubMed ID: 2856280
    [No Abstract]   [Full Text] [Related]  

  • 5. Does central nervous system toxicity occur in transplant patients with hypocholesterolemia receiving cyclosporine?
    Cooper DK; Novitzky D; Davis L; Huff JE; Parker D; Schlesinger R; Sholer C; Zuhdi N
    J Heart Transplant; 1989; 8(3):221-4. PubMed ID: 2661772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of toxic side effects of cyclosporine in heart transplantation.
    Schüler S; Warnecke H; Hetzer R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2518-21. PubMed ID: 3547936
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporine immunosuppression.
    Canafax DM; Ascher NL
    Clin Pharm; 1983; 2(6):515-24. PubMed ID: 6360494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival following hepatic transplantation in the cyclosporine era.
    Williams JW; Vera SR; Peters TG; Van Voorst S
    Am Surg; 1986 Jun; 52(6):291-3. PubMed ID: 3521421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical problems in cyclosporine dosing with reference to clinical pharmacology: case histories and discussion.
    Kahan BD
    Transplant Proc; 1989 Jun; 21(3 Suppl 1):16-40. PubMed ID: 2662534
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver transplantation: the initial experience of a Canadian centre.
    Wall WJ; Duff JH; Ghent CN; Stiller CR; Keown PA; Kutt JL
    Can J Surg; 1985 May; 28(3):286-9. PubMed ID: 3888358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse effects of cyclosporine therapy following liver transplantation.
    Grant D; Wall W; Duff J; Stiller C; Ghent C; Keown P
    Transplant Proc; 1987 Aug; 19(4):3463-5. PubMed ID: 3303518
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporine induced hemolytic anemia in a liver transplant patient.
    Faure JL; Causse X; Bergeret A; Meyer F; Neidecker J; Paliard P
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2242-3. PubMed ID: 2652727
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine approved for kidney, liver, and heart transplants.
    FDA Drug Bull; 1984 Apr; 14(1):6-7. PubMed ID: 6376250
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatic failure due to massive iron ingestion successfully treated with liver transplantation.
    Kozaki K; Egawa H; Garcia-Kennedy R; Cox KL; Lindsay J; Esquivel CO
    Clin Transplant; 1995 Apr; 9(2):85-7. PubMed ID: 7599407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased rate of growth of hepatocellular carcinoma recurrence after liver transplantation in patients maintained on cyclosporine immunosuppression.
    O'Grady JG; Johnson PJ; Zaman S; Calne RY; Williams R
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):394-6. PubMed ID: 2838941
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuropathology of liver transplantation.
    Blanco R; De Girolami U; Jenkins RL; Khettry U
    Clin Neuropathol; 1995; 14(2):109-17. PubMed ID: 7606896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine in auxiliary partial liver transplantation.
    de Rave S; Schalm SW; Willemse PJ; Weimar W; Terpstra OT
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):397-400. PubMed ID: 3291275
    [No Abstract]   [Full Text] [Related]  

  • 18. [Central pontine myelinolysis associated with cyclosporin in liver transplantation].
    Rodríguez J; Benito-León J; Molina JA; Ramos A; Bermejo F
    Neurologia; 1998 Nov; 13(9):437-40. PubMed ID: 9883020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Danish liver transplantation program and patients with serious acetaminophen intoxication.
    Larsen FS; Kirkegaard P; Rasmussen A; Hansen BA
    Transplant Proc; 1995 Dec; 27(6):3519-20. PubMed ID: 8540079
    [No Abstract]   [Full Text] [Related]  

  • 20. Conversion from standard cyclosporine to low-dose cyclosporine and azathioprine therapy as treatment for cyclosporine-related complications in liver transplant patients.
    Perkins JD; Sterioff S; Wiesner RH; Offord KP; Rakela J; Dickson ER; Krom RA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2434-6. PubMed ID: 3274533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.